인쇄하기
취소

The sales of Telminuvo, Exone, Naxozol and Duvie show increasing trend

Published: 2014-05-26 16:05:53
Updated: 2014-05-26 16:05:53

According to the prescription result per month of new drugs which are released within one year, Telminuvo, Exone, Naxozol and Duvie seem to be seated on the market smoothly.

Telminuvo is a hypertensive treatment which has the same component with a leading marketing item, Twinstar. It was released in the market with Twinstar last year, after the patent expiration of Telmisartan. Telminuvo made ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.